EPO Patents = 2

Average Co-Inventor Count = 3.1

ph-index = 12

Forward Citations = 462(Granted Patents)

Forward Citations (Not Self Cited) = 382(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Bradford, CT (US) (1992)
Crofton, MD (US) (1993)
Laurel, MD (US) (1995 - 1997)
Branford, CT (US) (1992 - 1998)
Banford, CT (US) (1998)
Ridgefield, CT (US) (2006 - 2010)
Danbury, CT (US) (1997 - 2012)

Company Filing History:

Achillion Pharmaceuticals, Inc.

patents

3 out of 1,217

The United States of America As Represented by the Department of Health

patents

4. 3 out of 1,323

G.d. Searle & Company

patents

5. 2 out of 29

Novartis International Pharmaceutical, Ltd.

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

8. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2012

Loading Chart...

Areas of Expertise:

C5a Receptor Modulators

Dopamine Receptor Ligands

Aryl Imidazoles

Amino Methyl Imidazoles

Viral Replication Inhibitors

Melanin Concentrating Hormone Receptor

Biaryl Amides

Pharmaceutical Compositions

Piperazine Derivatives

Imidazole Derivatives

GABA Brain Modulators

Aminomethyl Compounds

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8119665 - Aryl imidazoles and related compounds as C5a receptor modulators (2012-02-21),

2. 8007767 - Amino methyl imidazoles and related compounds as C5a receptor modulators (2011-08-30),

3. 7767706 - Substituted aryl acylthioureas and related compounds; inhibitors of viral replication (2010-08-03),

4. 7718671 - Substituted arylthiourea derivatives useful as inhibitors of viral replication (2010-05-18),

5. 7476686 - Substituted aryl thioureas and related compounds; inhibitors of viral replication (2009-01-13),

6. 7439374 - Azabenzofuran substituted thioureas; inhibitors of viral replication (2008-10-21),

7. 7365068 - Substituted aryl acylthioureas and related compounds; inhibitors of viral replication (2008-04-29),

8. 7323478 - Melanin concentrating hormone receptor ligands (2008-01-29),

9. 7271270 - High affinity small molecule C5a receptor modulators (2007-09-18),

10. 7186734 - Aryl imidazoles and related compounds as C5a receptor modulators (2007-03-06),

11. 7169775 - Amino methyl imidazoles as C5a receptor modulators (2007-01-30),

12. 7101887 - 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands (2006-09-05),

13. 7094807 - Substituted aryl thioureas and related compounds; inhibitors of viral replication (2006-08-22),

14. 6884815 - High affinity small molecule C5a receptor modulators (2005-04-26),

15. 6858637 - Substituted biaryl amides as C5a receptor modulators (2005-02-22),

Title: The Innovative Journey of Andrew Y Thurkauf

Introduction: Andrew Y Thurkauf is a distinguished inventor based in Branford, CT (US) known for his groundbreaking contributions to various fields.

Latest Patents: Andrew Y Thurkauf's latest patents include cutting-edge technologies in the healthcare sector, revolutionizing the way medical procedures are conducted.

Career Highlights: With a career spanning over two decades, Andrew Y Thurkauf has established himself as a pioneer in the field of medical device innovations, holding numerous patents that have significantly impacted the industry.

Collaborations: Throughout his career, Andrew Y Thurkauf has collaborated with leading research institutions and universities to further advance his inventions, showcasing his commitment to pushing the boundaries of innovation.

Conclusion: Andrew Y Thurkauf's relentless pursuit of innovation and his passion for creating solutions that improve lives make him a standout figure in the world of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com